Sales & Support: 314-485-5210



Catalogue number:
500 mg
Product is available in:
  • USA
  • Canada
$252.00 Shipping is calculated in checkout

Sorafenib is a multikinase inhibitor with activity against Raf kinase and several receptor tyrosine kinases, including vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), FLT3, Ret, and c-Kit. It suppresses ERK phosphorylation. It also induces the phosphorylation of PKA. Sorafenib has anti-tumor activity in HCC models may be attributed to inhibition of tumor angiogenesis (VEGFR and PDGFR) and direct effects on tumor cell proliferation/survival (Raf kinase signaling-dependent and signaling-independent mechanisms).

Product Type:

Peptides & proteins

CAS Number:


Alternative Names:

Bay 43-9006, Nexavar, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-Nmethyl-pyridine-2-carboxamide


1) Liu, L., et al. 2006. Cancer Res. 66(24): 11851-11858. PMID: 17178882; 2) Aleman, JO., et al. 2014. Endocr Relat Cancer. 21(3): R247-259. PMID: 24478055; 3) Wurth, R., et al. Biomed Res Int. 2014: 126586. PMID: 24527434

Limit of Detection:


Storage Temperature:

-20°C. Keep away from direct sunlight.

Shelf Life:

12 months from receipt